ZURICH, Oct 13 () - Swiss drugmaker Roche entered a licensing ‌agreement worth up to $1.16 billion ‌with Rona Therapeutics ...

The International Monetary Fund on Tuesday forecast global growth in 2026 would slow less than previously expected because of ...

Known as Volufiline, the agent swells the skin by chemically expanding fat cells and is used mostly in body creams. But after ...

Meetings & Events product, designed to make international event travel easier to organise. oneworld Meetings & Events ...

Procter & Gamble has delivered steady gains for long term shareholders, and with the stock recently closing at US$153.20 the ...

VEON has delivered a striking run in recent years, and the question now is whether the current price around US$80.81 still ...

Aegon (ENXTAM:AGN) stays in focus after investors reviewed fresh return data alongside its broad insurance footprint across ...

OSB Group buyback puts share count in focus OSB Group (LSE:OSB) has been actively buying back its own shares, cancelling ...

How AbbVie’s latest data releases are reshaping the story AbbVie (ABBV) has packed the early October news cycle with fresh ...

In France, pump prices are among the highest in the European Union. The government has moved to cut the price per litre by 12 ...

V.F (VFC) drew fresh attention after its stock rose 5.8% on October 13 as Barclays lifted its outlook, linking the move to ...

Airtel Mobile Commerce (LSE:AMC) has just completed a £529.2 million IPO, offering several tranches of common stock at £1.96 ...